OREX

Orexigen Therapeutics, Inc. News Headlines

$2.76
*  
0.06
2.22%
Get OREX Alerts
*Delayed - data as of Aug. 27, 2015  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Vivus Hovers Near 52-Week Lows - Qsymia Sales Not Helping
8/23/2015 5:06:00 PM - Seeking Alpha


Arena - Belviq Sales Will Pace Lower Than Last Year
8/23/2015 4:55:00 PM - Seeking Alpha








Vivus: Qsymia Sales Flat - Investors Need Caution Still
8/11/2015 4:04:00 AM - Seeking Alpha




Arena: Belviq Sales Trend - Investors Need Caution
8/10/2015 7:11:00 PM - Seeking Alpha














Vivus: Slower-Than-Needed Qsymia Sales Do Not Offer Hope
8/4/2015 4:27:00 AM - Seeking Alpha




Orexigen- Contrave Leading The Way In A Slow Race
8/3/2015 12:35:00 PM - Seeking Alpha




Vivus Reports Q2 Loss- Confirms Obesity Sector Weakness
7/31/2015 8:21:00 AM - Seeking Alpha




Orexigen: Contrave Sales Up 2.75% - Still No News On Europe
7/27/2015 11:48:00 AM - Seeking Alpha


Arena: Sales Flat Again- Belviq Still Losing Market Share
7/27/2015 10:15:00 AM - Seeking Alpha